242 related articles for article (PubMed ID: 15645481)
21. Comparison of treatment of tardive dystonia and idiopathic cervical dystonia with botulinum toxin type A.
Brashear A; Ambrosius WT; Eckert GJ; Siemers ER
Mov Disord; 1998 Jan; 13(1):158-61. PubMed ID: 9452343
[TBL] [Abstract][Full Text] [Related]
22. Predictors of response to botulinum toxin type A (BoNTA) in chronic daily headache.
Mathew NT; Kailasam J; Meadors L
Headache; 2008 Feb; 48(2):194-200. PubMed ID: 17868356
[TBL] [Abstract][Full Text] [Related]
23. Influence of age and gender on dose and effectiveness of botulinum toxin for laryngeal dystonia.
Vasconcelos S; Birkent H; Sardesai MG; Merati AL; Hillel AD
Laryngoscope; 2009 Oct; 119(10):2004-7. PubMed ID: 19572275
[TBL] [Abstract][Full Text] [Related]
24. Patients' perspective of botulinum toxin-A as a long-term treatment option for neurogenic detrusor overactivity secondary to spinal cord injury.
Hori S; Patki P; Attar KH; Ismail S; Vasconcelos JC; Shah PJ
BJU Int; 2009 Jul; 104(2):216-20. PubMed ID: 19220255
[TBL] [Abstract][Full Text] [Related]
25. Botulinum toxin type A in simple motor tics: short-term and long-term treatment-effects.
Rath JJ; Tavy DL; Wertenbroek AA; van Woerkom TC; de Bruijn SF
Parkinsonism Relat Disord; 2010 Aug; 16(7):478-81. PubMed ID: 20034838
[TBL] [Abstract][Full Text] [Related]
26. [Safety and tolerance of single-dose botulinum toxin Type A treatment in 204 patients with spasticity and localized associated symptoms. Austrian and German botulinum toxin A spasticity study group].
Wissel J; Müller J; Heinen F; Mall V; Sojer M; Ebersbach G; Poewe W
Wien Klin Wochenschr; 1999 Oct; 111(20):837-42. PubMed ID: 10586488
[TBL] [Abstract][Full Text] [Related]
27. Experience with 100 cases treated with botulinum-A toxin injections in the detrusor muscle for idiopathic overactive bladder syndrome refractory to anticholinergics.
Schmid DM; Sauermann P; Werner M; Schuessler B; Blick N; Muentener M; Strebel RT; Perucchini D; Scheiner D; Schaer G; John H; Reitz A; Hauri D; Schurch B
J Urol; 2006 Jul; 176(1):177-85. PubMed ID: 16753396
[TBL] [Abstract][Full Text] [Related]
28. The analgesic effect of botulinum-toxin A on postwhiplash neck pain.
Braker C; Yariv S; Adler R; Badarny S; Eisenberg E
Clin J Pain; 2008 Jan; 24(1):5-10. PubMed ID: 18180629
[TBL] [Abstract][Full Text] [Related]
29. Will suburothelial injection of small dose of botulinum A toxin have similar therapeutic effects and less adverse events for refractory detrusor overactivity?
Kuo HC
Urology; 2006 Nov; 68(5):993-7; discussion 997-8. PubMed ID: 17113890
[TBL] [Abstract][Full Text] [Related]
30. Long-term treatment with botulinum toxin type A in cervical dystonia has low immunogenicity by mouse protection assay.
Brin MF; Comella CL; Jankovic J; Lai F; Naumann M;
Mov Disord; 2008 Jul; 23(10):1353-60. PubMed ID: 18546321
[TBL] [Abstract][Full Text] [Related]
31. Botulinum toxin type a injections into the trigone to treat idiopathic overactive bladder do not induce vesicoureteral reflux.
Karsenty G; Elzayat E; Delapparent T; St-Denis B; Lemieux MC; Corcos J
J Urol; 2007 Mar; 177(3):1011-4. PubMed ID: 17296399
[TBL] [Abstract][Full Text] [Related]
32. [Usefulness of botulinum toxin in gastrointestinal disorders].
Zepeda-Gómez S; Valdovinos-Díaz MA
Rev Gastroenterol Mex; 2002; 67(2):126-33. PubMed ID: 12214336
[TBL] [Abstract][Full Text] [Related]
33. Long-term use of botulinum toxin type A in children with cerebral palsy: treatment consistency.
Molenaers G; Schörkhuber V; Fagard K; Van Campenhout A; De Cat J; Pauwels P; Ortibus E; De Cock P; Desloovere K
Eur J Paediatr Neurol; 2009 Sep; 13(5):421-9. PubMed ID: 18977158
[TBL] [Abstract][Full Text] [Related]
34. [Problems of treating writer's cramp with botulinum toxin injections: results from 10 years of experience].
Marion MH; Afors K; Sheehy MP
Rev Neurol (Paris); 2003 Oct; 159(10 Pt 1):923-7. PubMed ID: 14615682
[TBL] [Abstract][Full Text] [Related]
35. Response to botulinum toxin F in seronegative botulinum toxin A--resistant patients.
Greene PE; Fahn S
Mov Disord; 1996 Mar; 11(2):181-4. PubMed ID: 8684389
[TBL] [Abstract][Full Text] [Related]
36. Botulinum toxin A--injection for cervical dystonia.
Bhaumik S; Behari M
J Assoc Physicians India; 1999 Mar; 47(3):267-70. PubMed ID: 10999117
[TBL] [Abstract][Full Text] [Related]
37. Botulinum toxin for neurological disorders in a movement disorders clinic in Singapore.
Tan AK
Singapore Med J; 1998 Sep; 39(9):403-5. PubMed ID: 9885719
[TBL] [Abstract][Full Text] [Related]
38. Effectivity of Dysport in patients with blepharospasm and hemifacial spasm who experienced failure with Botox.
Badarny S; Susel Z; Honigman S
Isr Med Assoc J; 2008 Jul; 10(7):520-2. PubMed ID: 18751631
[TBL] [Abstract][Full Text] [Related]
39. Relationship of botulinum dosage to duration of side effects and normal voice in adductor spasmodic dysphonia.
Chang CY; Chabot P; Thomas JP
Otolaryngol Head Neck Surg; 2007 Jun; 136(6):894-9. PubMed ID: 17547976
[TBL] [Abstract][Full Text] [Related]
40. Pooled analysis of the safety of botulinum toxin type A in the treatment of poststroke spasticity.
Turkel CC; Bowen B; Liu J; Brin MF
Arch Phys Med Rehabil; 2006 Jun; 87(6):786-92. PubMed ID: 16731213
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
